Select Committee · Science, Innovation and Technology Committee

UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks

Status: Closed Opened: 20 Mar 2020 Closed: 16 Nov 2022 19 recommendations 8 conclusions 1 report

The Coronavirus covid-19 outbreak is the latest in a series of disease outbreaks that have spread internationally, presenting major challenges to communities, national governments and international institutions. Scientific knowledge and advice are foundational to the prevention, management and treatment of these global outbreaks, at both an international and national level. Once the covid-19 pandemic has … Show more

Reports

1 report
Title HC No. Published Items Response
First Report - The UK response to covid-19: use of scientif… HC 136 8 Jan 2021 27 Responded

Recommendations & Conclusions

27 items
1 Recommendation First Report - The UK response to covid… Accepted

The coronavirus pandemic marks the most significant test of the UK’s emergency advisory and decision-making...

The coronavirus pandemic marks the most significant test of the UK’s emergency advisory and decision-making structures in living memory. As such, it is important that lessons are drawn throughout and applied so that the Government and future Governments may be better placed to respond to future crises. This has been … Read more

Government response AI summary
The government commits to publishing scientific advice in a timely fashion, with a default for release, and outlines the roles of the new UK Health Security Agency (UKHSA) and the Joint Biosecurity Centre (JBC) in the longer-term management of the pandemic, providing clarity on the …
Read full response →
Department for Science, Innovation and Technology
2 Recommendation First Report - The UK response to covid… Deferred

The Cabinet Office and Government Office for Science should update SAGE guidance to set out...

The Cabinet Office and Government Office for Science should update SAGE guidance to set out the role that SAGE will play in advising the Government’s long-term management of emergency scenarios. (Paragraph 34) Activation and operation of SAGE

Government response AI summary
The government stated that responsibility for long-term emergency management sits with lead departments and SAGE is used case-by-case. It committed to learning from the Covid-19 response regarding how scientific advice can inform long-term emergency management, but did not explicitly commit to updating SAGE guidance to …
Read full response →
Department for Science, Innovation and Technology
3 Conclusion First Report - The UK response to covid… Not Addressed

We are satisfied that the SAGE mechanism responded to the advent of the novel coronavirus...

We are satisfied that the SAGE mechanism responded to the advent of the novel coronavirus in a timely manner and that the most up-to-date scientific research and understanding was readily available to inform the Government from the outset. Nevertheless, we note that submissions presented to us raised concerns that during … Read more

Government response AI summary
The government responded by stating that no other papers were commissioned for early SAGE meetings and that minutes are available, but did not address the committee's concern about the speed of policy decisions in response to scientific evidence.
Read full response →
Department for Science, Innovation and Technology
4 Recommendation First Report - The UK response to covid… Not Addressed

It is disappointing that the details of SAGE’s preliminary meetings were not made public for...

It is disappointing that the details of SAGE’s preliminary meetings were not made public for over two months, leading to unnecessary concern and confusion over what advice the Government had been receiving. Indeed, were it not for our early enquiries, this confusion may have continued until the details of SAGE’s … Read more

Government response AI summary
The government's response discusses the diversity of SAGE advisors and their expertise, but does not address the recommendation to confirm whether papers were considered at the first two SAGE meetings or commit to publishing them.
Read full response →
Department for Science, Innovation and Technology
5 Recommendation First Report - The UK response to covid… Not Addressed

We believe the initial response in setting up SAGE was timely.

We believe the initial response in setting up SAGE was timely. We have heard from some sectors of the science community that the community was not consulted appropriately. The Government should set out in response to this Report how in future emergencies it will engage formally and informally with the … Read more

Government response AI summary
The government expressed appreciation for scientific contributions and outlined support for SAGE participants and their universities, including future plans for recognition. However, it did not set out a plan for how it will formally and informally engage with the broader science community in future emergencies.
Read full response →
Department for Science, Innovation and Technology
6 Recommendation First Report - The UK response to covid… Not Addressed

SAGE has been activated for the longest continual period since its inception, which brings to...

SAGE has been activated for the longest continual period since its inception, which brings to question how sustainably the group can maintain its current level of high activity. We acknowledge senior scientists’ comments of frequent working round the clock, and we pay tribute to their continued service to the public … Read more

Government response AI summary
The government states it will consider revisions to SAGE guidance as part of a future review, focusing on participant identity publication and security risks, but does not specifically commit to updating guidance for adviser support in long-term emergencies or to formally recognise contributors.
Read full response →
Department for Science, Innovation and Technology
7 Recommendation First Report - The UK response to covid… Deferred

Whilst we welcome the eventual disclosure of SAGE participants, the fact that the delay was...

Whilst we welcome the eventual disclosure of SAGE participants, the fact that the delay was attributed to advice from the Centre for the Protection of National Infrastructure (CPNI) gives us cause for concern. As suggested by Professor Chris Whitty, the advice relates to emergencies relevant to national security rather than … Read more

Government response AI summary
The government states it will consider necessary revisions to SAGE guidance as part of a wider future review, but does not commit to updating the guidance within three months to stipulate timeframes for receiving CPNI advice regarding public disclosure of SAGE participants.
Read full response →
Department for Science, Innovation and Technology
8 Recommendation First Report - The UK response to covid… Not Addressed

Regarding the disclosure of Government officials observing SAGE meetings, we agree with the redaction of...

Regarding the disclosure of Government officials observing SAGE meetings, we agree with the redaction of information to protect the personal data of individuals including junior officials at the time of the emergency. In the interests of transparency, and to have a full picture of who is formulating policy advice to … Read more

Government response AI summary
The government response focuses on the Joint Biosecurity Centre's (JBC) publications, data, and the commitment to publish minutes and scope of its various boards, but it does not address the recommendation for full disclosure of SAGE attendees and observers.
Read full response →
Department for Science, Innovation and Technology
9 Recommendation First Report - The UK response to covid… Not Addressed

It is regrettable that full transparency was not achieved in time for the JBC’s inauguration...

It is regrettable that full transparency was not achieved in time for the JBC’s inauguration on 1 June. We welcome the disclosure of the expert advisory boards supporting the JBC. Nevertheless, the Department of Health and Social Care (DHSC) has yet to commit to publish the outputs, including meeting papers … Read more

Government response AI summary
The government response focuses on the transparency of SAGE publications and reasons for confidentiality, but does not commit to publishing the outputs or meeting schedules for the JBC's steering and advisory boards, as specifically requested by the committee.
Read full response →
Department for Science, Innovation and Technology
10 Recommendation First Report - The UK response to covid… Not Addressed

Given the frequent reporting of the views of SAGE advisers in the media— particularly where...

Given the frequent reporting of the views of SAGE advisers in the media— particularly where these have diverged from decisions taken by the Government— and the continued public interest in the evidence base underlying decisions made, we are satisfied for the most part that the demarcation between adviser and decision- … Read more

Government response AI summary
The government agreed on the importance of considering a wide range of factors and committed to publishing data that has informed its decision-making, including analysis and rationale for policy choices like the tiering framework. However, it did not commit to publishing specific science advice given …
Read full response →
Department for Science, Innovation and Technology
11 Recommendation First Report - The UK response to covid… Not Addressed

Transparency in the evidence behind Government decisions enables higher quality decision-making through scrutiny, and better...

Transparency in the evidence behind Government decisions enables higher quality decision-making through scrutiny, and better understanding of the reasons for those decisions. While calls for the publication of SAGE evidence from this Committee and many others were eventually heeded, it is regrettable that a significant amount of time passed before … Read more

Government response AI summary
The government's response describes its efforts to understand the wider health impacts of Covid-19 and the methodology for reporting deaths, but it does not address the committee's specific recommendation regarding the rigour and relevance of analysis selected for public presentation to avoid public alarm.
Read full response →
Department for Science, Innovation and Technology
12 Recommendation First Report - The UK response to covid… Accepted in Part

It has been made clear to us that policy decisions throughout the coronavirus pandemic have...

It has been made clear to us that policy decisions throughout the coronavirus pandemic have not been based solely on medical and epidemiological science, but rather have been developed with a wide range of inputs that include scientific research and opinion. Nevertheless, as indicated by the Government Chief Scientific Adviser, … Read more

Government response AI summary
The government states it will work to evolve SAGE guidance on transparency and points to existing publications and data sources that provide information on the direct and indirect impacts of COVID-19, including metrics used for policy decisions, and commits to future investment in data and …
Read full response →
Department for Science, Innovation and Technology
13 Recommendation First Report - The UK response to covid… Not Addressed

The public has shown a strong appetite for more information.

The public has shown a strong appetite for more information. The Government should attempt to quantify the four forms of health impacts identified by Professor Whitty. Further, it should consider whether it is possible to provide an analysis of—either consistently or on a sample basis—those who died with covid-19 as … Read more

Government response AI summary
The government's response details its efforts to communicate scientific advice during the pandemic, but does not address the recommendation to quantify health impacts or provide analysis distinguishing between those who died with or from Covid-19.
Read full response →
Department for Science, Innovation and Technology
14 Recommendation First Report - The UK response to covid… Not Addressed

As indicated by the Chief Medical Officer for England, the SAGE secretariat faced “huge pressure”...

As indicated by the Chief Medical Officer for England, the SAGE secretariat faced “huge pressure” in managing the monumental task of organising SAGE whilst adhering to the principles of transparent and scrutable scientific advice. We commend the efforts of officials in the Government Office for Science, the SAGE secretariat and … Read more

Government response AI summary
The government response details how it considers and mitigates indirect impacts of COVID-19, describes decision-making structures, and lists various metrics. However, it does not address the recommendation to update SAGE guidance specifically on managing transparency during emergencies.
Read full response →
Department for Science, Innovation and Technology
15 Recommendation First Report - The UK response to covid… Not Addressed

We applaud the dedication with which the scientific community within the UK and globally have...

We applaud the dedication with which the scientific community within the UK and globally have directly engaged with the public, in addition to their intensive studies of the coronavirus itself. We are also grateful to those within universities and research institutes for their efforts in supporting the clear and direct … Read more

Government response AI summary
The government's response focused on improvements in data access, sharing, and integration across government and devolved administrations, including the role of the JBC. This response did not address the recommendation to identify lessons learned from the communication of science or to update SAGE guidance regarding …
Read full response →
Department for Science, Innovation and Technology
16 Recommendation First Report - The UK response to covid… Not Addressed

We believe that a gap persists in the transparency of the advice that is given...

We believe that a gap persists in the transparency of the advice that is given to the Government, outside of the auspices of SAGE, particularly on the topic of non- medical impacts of the pandemic and related Government interventions. While this Committee is not advocating the establishment of an “economics … Read more

Government response AI summary
The government response details its approach to test, trace, and isolate, including regional engagement teams and the functions of the JBC, as well as funding for local authorities. It does not, however, set out how advice on indirect effects of COVID-19 interventions has been structured …
Read full response →
Department for Science, Innovation and Technology
17 Recommendation First Report - The UK response to covid… Not Addressed

Given the UK’s strengths in statistical analysis and data science, it is regrettable that poor...

Given the UK’s strengths in statistical analysis and data science, it is regrettable that poor data flows, delays in data-sharing agreements and a general lack of structuring and data integration across both the health and social care sectors have throttled timely data sharing and analysis. For example, it is unacceptable … Read more

Government response AI summary
The government's response focused entirely on the GCSA, CMO, and SAGE participants' engagement with international counterparts and organizations to share information and learn lessons. It did not address the recommendation for DHSC to set out an action plan for addressing poor data access, data sharing …
Read full response →
Department for Science, Innovation and Technology
18 Conclusion First Report - The UK response to covid… Not Addressed

We are satisfied that the science advice informing the Government has drawn upon some of...

We are satisfied that the science advice informing the Government has drawn upon some of the best expertise that the UK—and indeed the world—has to offer. We acknowledge the initial dominance of modelling expertise on SAGE and believe this is a fair reflection of the lack of data at the … Read more

Government response AI summary
The government's response detailed its ongoing review of non-pharmaceutical interventions and social distancing rules, highlighting its collaboration with scientific advisers and consideration of international and devolved administration approaches in policy decisions. It did not directly address the committee's conclusion regarding the breadth and evolution of …
Read full response →
Department for Science, Innovation and Technology
19 Conclusion First Report - The UK response to covid… Not Addressed

The Government was too slow to increase testing capacity to the levels required to help...

The Government was too slow to increase testing capacity to the levels required to help contain the spread of the coronavirus. We have previously suggested that strategy was driven by the capacity available, rather than strategy driving the necessary increase in capacity. It was clear early in the year that … Read more

Government response AI summary
The government's response describes its belief in a combined national and local approach for test, trace, and isolate, and how NHS Test and Trace was designed for integrated service. However, it does not address the committee's specific criticism regarding the slowness to increase testing capacity …
Read full response →
Department for Science, Innovation and Technology
20 Conclusion First Report - The UK response to covid… Not Addressed

The Government was slow to move once it realised that coronavirus testing required a rapid...

The Government was slow to move once it realised that coronavirus testing required a rapid expansion and did not engage sufficiently with the wide array of scientific expertise available within the UK—particularly within our universities and research institutes. While we appreciate the complexities of such a feat, including the need … Read more

Government response AI summary
The government's response explains its integrated national and local approach for test, trace, and isolate, and how NHS Test and Trace was designed with local engagement. However, it does not address the committee's criticism regarding the slowness to expand testing capacity or the insufficient engagement …
Read full response →
Department for Science, Innovation and Technology
21 Conclusion First Report - The UK response to covid… Acknowledged

The Committee will report separately and more fully on the test, trace and isolate system...

The Committee will report separately and more fully on the test, trace and isolate system and the mass testing programme in due course. But in considering the role of science advice, and its influence on Government decisions, we are concerned by the continued lack of justification provided to the Committee … Read more

Government response AI summary
The government explains its belief that a combined national and local approach for test, trace, and isolate is best, detailing how NHS Test and Trace was designed with local engagement to be an integrated service from the outset.
Read full response →
Department for Science, Innovation and Technology
22 Conclusion First Report - The UK response to covid… Acknowledged

The creation of NHS Test and Trace involves a budget of £22 billion for financial...

The creation of NHS Test and Trace involves a budget of £22 billion for financial year 2020–21 and the justification for most of its spending being on the central part of the system, rather than through local public health teams, has not been clearly made. Concerns have also been raised … Read more

Government response AI summary
The government justifies its combined national and local approach for NHS Test and Trace, stating it was always intended to be integrated and has involved extensive local engagement through Regional Engagement Teams and partnerships. It explains that this multi-faceted approach is best suited for delivering …
Read full response →
Department for Science, Innovation and Technology
23 Recommendation First Report - The UK response to covid… Accepted in Part

The Government should: explain clearly the justification for taking a relatively centralised approach to test,...

The Government should: explain clearly the justification for taking a relatively centralised approach to test, trace and isolate; set out its assessment of the impact of the system on the spread of the virus since the outset, including on health outcomes; and review the balance between the local and national … Read more

Government response AI summary
The government explains its rationale for an integrated national and local Test and Trace system, detailing how it works with local partners and its intention to combine approaches. However, it does not provide an assessment of the system's impact on virus spread or health outcomes, …
Read full response →
Department for Science, Innovation and Technology
24 Recommendation First Report - The UK response to covid… Acknowledged

Throughout the pandemic, the UK has relied on its own bespoke system of science advice...

Throughout the pandemic, the UK has relied on its own bespoke system of science advice and guidance on non-pharmaceutical interventions, while at the same time global-level guidance has been issued regularly by the World Health Organisation (WHO). There have also been numerous opportunities to learn from the approaches undertaken by … Read more

Government response AI summary
The government states it keeps non-pharmaceutical interventions under constant review and engages in regular dialogue with other countries, considering international approaches in its policy decisions. However, it does not commit to a specific review of the relationship between SAGE, international advisory structures, and the WHO …
Read full response →
Department for Science, Innovation and Technology
25 Recommendation First Report - The UK response to covid… Acknowledged

Given the importance of refining interventions to mitigate both impacts on public health and economic...

Given the importance of refining interventions to mitigate both impacts on public health and economic recovery, a review of social distancing measures came quite late. While the scientific approach quite rightly waits for the evidence before making a definitive recommendation, this often necessitates delay and may not produce conclusive results. … Read more

Government response AI summary
The government states it keeps NPIs and social distancing under constant review and is conducting a review of these measures, collaborating with advisors and engaging with other countries. However, it does not commit to a specific comparative review against SARS/MERS countries or to publishing findings …
Read full response →
Department for Science, Innovation and Technology
26 Conclusion First Report - The UK response to covid…

The development of vaccines and therapeutics is a policy area in which it is right...

The development of vaccines and therapeutics is a policy area in which it is right that science must lead the way, so that there may be a high level of confidence that a rigorous approach has been taken towards safety and efficacy. From the beginning of the pandemic, the clear … Read more

Department for Science, Innovation and Technology
27 Conclusion First Report - The UK response to covid…

We acknowledge that a large part of the success to date into the development of...

We acknowledge that a large part of the success to date into the development of covid-19 vaccines and therapeutics can be credited to lessons learned from previous outbreaks and efforts made to prepare for future crises. As further promising vaccine candidates and treatments come to light, other aspects of the … Read more

Department for Science, Innovation and Technology

Oral evidence sessions

27 sessions
Date Witnesses
30 Mar 2022 Professor Ann John · Scientific Pandemic Insights Group on Behaviours (SPI-B)., Sir Patrick Vallance, Government Chief Scientific Adviser · UK Government View ↗
2 Mar 2022 Dr Camilla Holten-Møller · Statens Serum Institut, Denmark, Dr Raghib Ali · MRC Epidemiology Unit, the University of Cambridge, Dr Sarah Scobie · Nuffield Trust, Ed Humpherson · UK Statistics Authority, Professor Graham Medley · Scientific Pandemic Influenza Group on Modelling (SPI-M). View ↗
14 Dec 2021 Dame Kate Bingham · UK Vaccine Taskforce, Dr Angelique Coetzee · South African Medical Association, Dr Paul Burton · Moderna, Dr Susan Hopkins · UK Health Security Agency, Professor Steven Riley · UK Health Security Agency, Professor Wei Shen Lim · JCVI COVID-19 sub-committee View ↗
26 Oct 2021 Dr Sharon Alroy-Preis · Public Health Services, Israel, Dr Thomas Waite · Department for Health and Social Care, Professor Andrew Curran · Health and Safety Executive, Professor Lucy Chappell · Department of Health and Social Care, Professor Mario Mondelli · University of Pavia, Professor Sir Andrew Pollard · Joint Committee on Vaccination and Immunisation, Professor Sir Stephen Holgate · University of Southampton View ↗
16 Jun 2021 Dr Susan Hopkins · UK Health Security Agency, Professor Sir Andrew Pollard · Joint Committee on Vaccination and Immunisation, Professor Wendy Barclay · Imperial College London View ↗
28 Apr 2021 Dr Mary Ramsay · UK Health Security Agency (UKHSA), Dr Ruth Payne · University of Sheffield, Professor Anthony Harnden · Joint Committee on Vaccination and Immunisation, Professor Christopher Dye · University of Oxford, Professor John Aston · University of Cambridge, Professor Ran Balicer · Clalit Research Institute, Professor Sir Munir Pirmohamed · Commission on Human Medicines View ↗
9 Mar 2021 Professor Chris Whitty, Chief Medical Officer for England · Department of Health and Social Care, Sir Patrick Vallance, Government Chief Scientific Adviser · UK Government View ↗
24 Feb 2021 Dr Philip Dormitzer · Pfizer, Madelaine McTernan · Department for Business, Energy and Industrial Strategy, Nadhim Zahawi · Department for Health and Social Care, Professor Anthony Harnden · Joint Committee on Vaccination and Immunisation, Professor Sarah Gilbert · University of Oxford, Professor Wendy Barclay · Imperial College London View ↗
17 Feb 2021 Dr James Rubin · Kings College London, Dr Johanna Hutchinson · Joint Biosecurity Centre, James Hetherington · Joint Biosecurity Centre, Professor Dame Angela McLean · HM Government, Professor Mark Woolhouse OBE · University of Edinburgh, Professor Sir John Bell · Oxford University View ↗
3 Feb 2021 Mark Hewlett · NHS Test and Trace, Steve McManus · NHS Test and Trace, The Baroness Harding of Winscombe · National Institute for Health Protection View ↗
27 Jan 2021 Dr Richard Harling MBE · Staffordshire County Council, Greg Fell · Association of Directors of Public Health View ↗
13 Jan 2021 Antonia Williams · HM Treasury, Dr Mary Ramsay · UK Health Security Agency (UKHSA), Nadhim Zahawi · Department for Health and Social Care, Professor Wei Shen Lim · JCVI COVID-19 sub-committee, Sir Mene Pangalos · AstraZeneca, Tom Keith-Roach · AstraZeneca UK View ↗
3 Nov 2020 Professor Chris Whitty, Chief Medical Officer for England · Department of Health and Social Care, Sir Patrick Vallance, Government Chief Scientific Adviser · UK Government, The Lord Patel KT · House of Lords View ↗
17 Sep 2020 Dr Susan Hopkins · UK Health Security Agency, Dr Thomas Waite · Department for Health and Social Care, Professor Carl Heneghan · University of Oxford, Professor Sylvia Richardson · Cambridge Institute of Public Health, University of Cambridge, Simon Thompson · Royal Mail, The Baroness Harding of Winscombe · National Institute for Health Protection, The Lord Bethell · Department for Health and Social Care View ↗
21 Jul 2020 Rt Hon Matt Hancock · Department for Health and Social Care, Sir Chris Wormald · Department of Health and Social Care View ↗

Who gave evidence

95 witnesses
WitnessOrganisationSessions
Sir Patrick Vallance, Government Chief Scientific Adviser · Former Chief Scientific Adviser to the UK Governm… UK Government 4
Dr Susan Hopkins · Chief Medical Advisor UK Health Security Agency 3
Professor Chris Whitty, Chief Medical Officer for England Department of Health and Social Care 3
Dr James Rubin · Professor of Psychology & Emerging Health Risks Kings College London 2
Dr Mary Ramsay · Director of Public Health Programmes UK Health Security Agency (UKHSA) 2
Dr Thomas Waite · Deputy Chief Medical Officer Department for Health and Social Care 2
Nadhim Zahawi · Minister for COVID Vaccine Deployment Department for Health and Social Care 2
Professor Andrew Curran · Chief Scientific Adviser and Director of Research Health and Safety Executive 2
Professor Anthony Harnden · Deputy Chair Joint Committee on Vaccination and Immunisation 2
Professor Graham Medley · Chair Scientific Pandemic Influenza Group on Modelling (SPI-M). 2
Professor John Aston · Harding Professor of Statistics in Public Life University of Cambridge 2
Professor Mark Woolhouse OBE · Professor of Infectious Disease Epidemiology University of Edinburgh 2
Professor Sarah Gilbert · Professor of Vaccinology University of Oxford 2
Professor Sir Andrew Pollard · Chair Joint Committee on Vaccination and Immunisation 2
Professor Sir John Bell · Regius Professor of Medicine Oxford University 2
Professor Wei Shen Lim · Chair JCVI COVID-19 sub-committee 2
Professor Wendy Barclay · Head of the Department of Infectious Disease Imperial College London 2
The Baroness Harding of Winscombe · Interim Executive Chair National Institute for Health Protection 2
Antonia Williams · Director of Public Services HM Treasury 1
Dame Kate Bingham · Chair (May-December 2020) UK Vaccine Taskforce 1
Dr Angelique Coetzee · Chair South African Medical Association 1
Dr Camilla Holten-Møller · Chair, the Expert Group for Mathematical Modelling Statens Serum Institut, Denmark 1
Dr Frank Atherton, Chief Medical Officer for Wales 1
Dr Gregor Smith, Interim Chief Medical Officer for Scotland 1
Dr Johanna Hutchinson · Director for Data and Data Science Joint Biosecurity Centre 1
Dr Jonathan Sheffield · COVID-19 Research Operations Director National Institute for Health Research 1
Dr Michael McBride, Chief Medical Officer for Northern Ireland 1
Dr Nicholas Davies · Research Fellow in Mathematical Modelling London School of Hygiene and Tropical Medicine 1
Dr Paul Burton · Chief Medical Officer Moderna 1
Dr Philip Dormitzer · Vice President and Chief Scientific Officer of Vi… Pfizer 1
Dr Raghib Ali · Senior Clinical Research Associate MRC Epidemiology Unit, the University of Cambridge 1
Dr Richard Harling MBE · Director of Health and Care Staffordshire County Council 1
Dr Ruth Payne · NIHR Academic Clinical Lecturer and Honorary Spec… University of Sheffield 1
Dr Sarah Scobie · Deputy Director of Research Nuffield Trust 1
Dr Seon Kui Lee · Director, Division of Risk Assessment and Interna… Korea Centers for Disease Control and Prevention (KCDC) 1
Dr Sharon Alroy-Preis · Director Public Health Services, Israel 1
Ed Humpherson UK Statistics Authority 1
Greg Fell · President Association of Directors of Public Health 1
James Hetherington · Chief Data Science Adviser Joint Biosecurity Centre 1
Kate Bingham · Chair UK Vaccine Taskforce 1
Showing 40 of 95.

Correspondence

71 letters
DateDirectionTitle
23 Jun 2022 Correspondence from Rt Hon Sajid Javid MP, Secretary of State for Health and So…
26 May 2022 Correspondence from the Chair to Rt Hon Sajid Javid MP, Secretary of State for …
20 May 2022 Correspondence from Rt Hon Sajid Javid MP, Secretary of State for Health and So…
27 Apr 2022 Correspondence from the Chair to Rt Hon Sajid Javid, Secretary of State for Hea…
17 Dec 2021 Correspondence from Rt Hon Sajid Javid MP, Secretary of State for Health and So…
21 May 2021 Correspondence from Dr Mary Ramsay, Head of Immunisation, Public Health England…
12 May 2021 Correspondence from Rt Hon Matt Hancock MP, Secretary of State for Health and S…
16 Mar 2021 Correspondence from Baroness Harding to Chair regarding contact tracing in Scot…
2 Mar 2021 Correspondence from Jeane Freeman MSP, Cabinet Secretary for Health and Sport, …
12 Feb 2021 Correspondence from Professor Wei Shen Lim to the Chair relating to follow up e…
12 Feb 2021 Correspondence from Baroness Harding to the Chair relating to the impact of Tes…
5 Feb 2021 Correspondence from the Chair to Baroness Harding regarding follow up evidence
3 Feb 2021 Correspondence from the Chair to Rt Hon Matt Hancock, Secretary of State for He…
20 Jan 2021 Correspondence from Nadhim Zahawi MP, Minister for COVID-19 Vaccine Deployment,…
13 Jan 2021 Correspondence from Dr Clive Dix, Interim Chair UK Vaccine Taskforce, to the Ch…
23 Dec 2020 Correspondence from the Chair to Dr Clive Dix, Interim Chair UK Vaccine Taskfor…
10 Dec 2020 Correspondence from the Prime Minister to the Chairs of the Science & Technolog…
11 Nov 2020 Correspondence from Professor Chris Whitty, Chief Medical Officer for England, …
4 Nov 2020 Correspondence from the Rt Hon Alok Sharma MP to the Chair regarding the Vaccin…
4 Nov 2020 Correspondence from the Chair to Rt Hon Alok Sharma MP relating to the Vaccine …

Meetings & visits

2 items
DateTypeDetail
23 Dec 2020 Formal meeting · Room 6, Palace of Westminster
15 Sep 2020 Formal meeting (private meeting) Private Meeting · Virtual meeting